Essentialis, Inc. clinical trials
Acquired by Neurocrine Biosciences, May 17, 2026 · source ↗
The registry lists 8 studies whose lead sponsor is Essentialis, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 9, 2016.
Before and after it joined Neurocrine Biosciences
- First submitted before Essentialis, Inc. became part of Neurocrine Biosciences
- 8
- First submitted after Essentialis, Inc. became part of Neurocrine Biosciences
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Essentialis, Inc.8 studies
Something wrong with this grouping? Tell us on the Neurocrine Biosciences page.
Studies
Recruiting first, then most recently updated. Showing 8 of 8. All Neurocrine Biosciences studies →
- A 5 Treatment Period Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR)Status unknownNCT02893618Phase 2
Sponsor listed in the registry: Essentialis, Inc. · First submitted before Essentialis, Inc. became part of Neurocrine Biosciences
- Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide CholineWithdrawnNCT00901823Phase 1
Sponsor listed in the registry: Essentialis, Inc. · First submitted before Essentialis, Inc. became part of Neurocrine Biosciences
- Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High TriglyceridesWithdrawnNCT00973271Phase 3
Sponsor listed in the registry: Essentialis, Inc. · First submitted before Essentialis, Inc. became part of Neurocrine Biosciences
- Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi SyndromeCompletedNCT02034071Phase 1/2
Sponsor listed in the registry: Essentialis, Inc. · First submitted before Essentialis, Inc. became part of Neurocrine Biosciences
- Pharmacokinetic Study of Diazoxide Choline in Hypertriglyeridemic SubjectsCompletedNCT01211860Phase 1
Sponsor listed in the registry: Essentialis, Inc. · First submitted before Essentialis, Inc. became part of Neurocrine Biosciences
- Efficacy Study of Diazoxide Choline to Treat HypertriglyceridemiaCompletedNCT01211847Phase 2
Sponsor listed in the registry: Essentialis, Inc. · First submitted before Essentialis, Inc. became part of Neurocrine Biosciences
- Open-label Pharmacokinetic Study of Diazoxide Choline Coated vs. Uncoated FormulationsCompletedNCT00688857Phase 1
Sponsor listed in the registry: Essentialis, Inc. · First submitted before Essentialis, Inc. became part of Neurocrine Biosciences
- Diazoxide Choline in HypertriglyceridemiaCompletedNCT00696475Phase 2
Sponsor listed in the registry: Essentialis, Inc. · First submitted before Essentialis, Inc. became part of Neurocrine Biosciences